Maintal, Germany

Klaus Paulini

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 65(Granted Patents)


Company Filing History:


Years Active: 2006-2013

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Klaus Paulini: Pioneering Innovator with Eight Notable Patents

Introduction:

In the world of innovation and patent development, Klaus Paulini from Maintal, Germany, stands out as a remarkable inventor. With eight patents to his name, he has made invaluable contributions to the field of pharmaceutical research. Let's delve into his latest patents and explore his notable achievements.

Patent 1: Triazole derivatives with improved receptor activity and bioavailability properties

Klaus Paulini's groundbreaking invention revolves around novel triazole derivatives. These compounds, as ghrelin antagonists, exhibit improved receptor activity and bioavailability properties. By targeting growth hormone secretagogue receptors, they hold tremendous potential for treating or preventing various physiological and pathophysiological conditions. These include alcohol disorder, drug abuse, growth retardation, diabetes, obesity, and more.

Patent 2: Tetrahydrocarbazole derivatives as ligands of G-protein coupled receptors

Another significant contribution by Klaus Paulini is his invention of tetrahydrocarbazole compounds. Serving as ligands of G-protein coupled receptors (GPCR), these compounds demonstrate effectiveness in the treatment and prophylaxis of several physiological and pathological conditions. These receptors play a pivotal role in modulating various biological processes and are key targets for therapeutic interventions.

Work Experience:

Klaus Paulini's expertise has been honed through his tenure at reputable pharmaceutical companies. He has worked at Aeterna Zentaris GmbH and Zentaris AG, where he played a crucial role in advancing research and development initiatives. Collaborating with esteemed colleagues such as Peter Schmidt and Michael Teifel, he has undoubtedly contributed to cutting-edge discoveries within the industry.

Conclusion:

Klaus Paulini's impressive portfolio of patents reflects his profound impact on the field of pharmaceutical innovation. With his groundbreaking inventions, he has unlocked potential treatments for a wide range of physiological and pathophysiological conditions. Through his diligent work and collaboration, he has proven himself as an integral force within the industry. Klaus Paulini serves as an inspiration to aspiring inventors and researchers, showcasing the power of innovation, dedication, and expertise in shaping the future of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…